Page 79 - IJB-8-3
P. 79

Alshehri, et al.
           optimized using the java codon adaptation online    of ×1. Gelation occurred within a few minutes at 8 mg/
           tool JCat for  Halobacterium sp. (strain NRC-1/ATCC   mL peptide concentration.
           700922/JCM 11081) [48] .  The gas vesicle operon from
           Halobacterium  sp.  NRC-1  was  amplified  from  the   2.5. 2D cell culture
           genome using polymerase chain reaction (PCR) and    HEK293  cells were purchased from  ATCC (USA).
           cloned with sfGFP via  FspAI-HpaI and  HpaI-BamHI   Cells were cultured in DMEM-HG, supplemented with
           using the Gibson Assembly Cloning Kit into pTA963   10% (v/v) fetal bovine serum (FBS) and 1% penicillin/
           to generate the pTA963_sfGFP_GVNPs expression       streptomycin  (PS; Gibco)  at  37°C  with  5%  CO . The
           plasmid (Table  1).  The construct was validated by   cells were subcultured with trypsin at approximately 80%
                                                                                                         2
           restriction digestion using  FspAI,  HpaI, and  BamHI,   confluence. The culture media were changed every 2 –
           PCR amplification, and DNA sequencing. Gas vesicles   3 days. Cells at passages 6 – 8 were encapsulated for 3D
           containing the vector were transformed into H. volcanii   culture and monolayer culture.
           H1895 using the PEG/EDTA method [49] .

           2.3. Culturing and gas vesicle preparation          2.6. 3D cell culture
                                                               HEK293 cells were cultured in 75T flasks and incubated in
           The processes for producing and culturing gas vesicles   a CO  incubator maintained at 37°C with 5% CO . Culture
           were performed as previously described [27,30,47] .  H.   media were replaced every 48 h until the cells reached 80%
                                                                   2
                                                                                                       2
           volcanii  lawns  or  floating  cells  were  lysed  osmotically
           with phosphate-buffered saline (PBS) solution (137 mM   confluency. Confluent cells were subcultured, and cells at
           NaCl, 2.7 mM KCl, 10 mM sodium phosphate dibasic,   passages 6 – 8 were used for the study. For the 3D culture,
           and 2 mM potassium  phosphate  monobasic  [pH  7.4])   the peptide was sterilized by exposure to ultraviolet light
           containing 10  mM MgSO  and 20  μg/mL of DNase  I   for 30 min. 10,000 cells in ×2 PBS were mixed at a 1:1
                                 4
           (Sigma-Aldrich,  USA). The  cell  lysate  suspension was   ratio with peptide solution and used to prepare 100 μl of
           incubated for 1 h at 37°C before overnight centrifugation   3D construct in a 96-well plate without the addition of
           at 60× g in a swinging bucket rotor in an Allegra X-15R   GVNPs to serve as a control. Different concentrations of
           centrifuge  (Beckman Coulter, CA, USA)  to accelerate   GVNPs were obtained by mixing with PBS before adding
           floatation  of  the  gas  vesicles.  Intact  gas  vesicles  were   them to form 3D samples. This allowed for the evaluation
           collected  and  re-suspended  in  PBS,  then  floated  by   of the GVNPs effect on cell proliferation.
           overnight  centrifugation  and  harvested  again.  This   2.7. 3D bioprinting
           floatation  procedure  was  repeated  until  a  white,  milky
           suspension of gas vesicles  was obtained.  Gas vesicle   16 mM of IK  peptide was diluted  in 1  mL of MilliQ
                                                                           6
           concentration  was  quantified  via  NanoDrop  2000   water, mixed well, and sonicated to assure a homogenous
           spectrophotometer  (Thermo  Scientific,  Waltham,  MA,   solution. Eight million cells were suspended in ×1 PBS
           USA) by measuring a small sample of gas vesicles broken   without GVNPs (control). When printing with GVNPs,
           by sonicating for several minutes.                  the cells were mixed with a ×1 PBS containing GVNPs at
                                                               a 300 μg/ml concentration.
           2.4. Hydrogel preparation                               A custom-designed 3D  bioprinter along with
           The ultrashort peptide  IK  (Ac-ILVAGK-NH2)  used in   commercial microfluidic pumps was set up (Figure S1) as
                                 6
           this study was synthesized by Bachem AG (Budendorf,   described in our previous publications, and a homemade
           Switzerland)  using solid-phase peptide  synthesis and   dual coaxial nozzle was used for bioink extrusion [40,41,50]   .
           purified to above 95% through high-performance liquid   Structures were printed in the shape of a rectangular
           chromatography. Amino acid and peptide content analyses   prism with a length, width, and height of 10 mm, 10 mm,
           were performed. The lyophilized peptide powders were   and  1.5  mm,  respectively.  Illustrated  figure  of  the
           first dissolved in Milli-Q water and mixed by vortexing   printed structure along with the printer setup is shown in
           for 30 s to obtain a homogenous solution. Then, ×10 PBS   Figure 1. To facilitate imaging, the structure was printed
           was added to the peptide solution for a final concentration   onto an 18 × 18 mm glass coverslip. The glass coverslip

           Table 1. Oligonucleotides used in this study.
           Primer      5’‑3’ sequence
           pTA.1       GGACCTATTGCGCATATGCACCACCACCACCACCACATGCGCATAATTCAATCGATACGAGTCCCG
           pTA.2       AATGCGATGGTCCAGAGGTGCGGCCGCTCTAGAACTAGTGGATCCGATCTGTGAGTGTACACCCC
           HpaI-BamHI TGTCTCTTCTTCCTCGTTAACGGTACCGGCGGATTCTCC
           FspAI-HpaI GCGGAGAATCCGCCGGTACCGTTAACGAGGAAGAAGAGACAGAGCC

                                       International Journal of Bioprinting (2022)–Volume 8, Issue 3        71
   74   75   76   77   78   79   80   81   82   83   84